Burn Wound Composition Using Composite Material Principles

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for non-healing burn wounds are ineffective, leading to prolonged healing times, high economic burdens, and a significant risk of scar formation, with limited therapeutic options available.

Innovation Solution

A composition comprising specific ratios of fatty acids, organic substances, carbohydrates, vitamins, microelements, antibiotics, and amino acids is developed to promote wound repair, inhibit infection, and reduce scar formation, featuring a combination of oleic acid, linoleic acid, palmitic acid, ellagic acid, calcium, zinc, and antibiotics like mupirocin, which are mixed in specific parts by weight to enhance therapeutic effects.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional treatments are used for non-healing burn wounds, then treatment duration is prolonged, but healing effectiveness remains insufficient

Engineering Contradiction:
Improvehealing effectivenessVSAvoidtreatment duration
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent applies composite materials by formulating a topical ointment containing multiple active ingredients including epithelializing agents (beta-carotene, vitamin A, vitamin B6, vitamin C, vitamin E), antibiotics (neomycin, polymyxin B, gentamicin), and other therapeutic components in specific concentrations. This multi-component composite formulation addresses the complexity of burn wound healing by simultaneously providing epithelial regeneration, infection prevention, and anti-inflammatory effects, thereby improving healing effectiveness while potentially reducing treatment duration compared to single-agent therapies

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent employs parameter changes by optimizing the concentration ranges of each ingredient in the ointment formulation. For example, beta-carotene is specified at 2-10 mg/g, vitamin A at 1-5 mg/g, and antibiotics at specific concentration ranges. These precise parameter optimizations ensure maximum therapeutic effectiveness while minimizing treatment time, directly addressing the contradiction between healing effectiveness and treatment duration

Inventive Principle:
Principle #35Parameter changes

2Productivity

If aggressive wound treatment is applied, then healing speed may increase, but risk of scar formation and relapse increases

Engineering Contradiction:
Improvewound healing speedVSAvoidscar formation risk
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent uses parameter changes by carefully controlling the concentration of active ingredients to achieve optimal healing speed while minimizing scar formation. The specified ranges for vitamins (e.g., vitamin C at 5-20 mg/g, vitamin E at 1-5 mg/g) and other components are optimized to promote rapid epithelialization without excessive inflammation that could lead to scarring. This balanced parameter optimization resolves the contradiction between healing speed and scar risk

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent converts potentially harmful effects into beneficial outcomes by using antioxidants (vitamin C, vitamin E, beta-carotene) to neutralize free radicals that would otherwise cause tissue damage and scarring. The anti-inflammatory components transform the harmful inflammatory response into a controlled healing process, achieving fast wound closure while minimizing scar formation and relapse risk

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Reliability

If multiple treatment components are combined, then therapeutic effectiveness improves, but formulation complexity increases

Engineering Contradiction:
Improvetherapeutic effectivenessVSAvoidformulation complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies merging by combining multiple therapeutic agents into a single topical ointment formulation. The ointment integrates epithelializing agents (beta-carotene, vitamins A, B6, C, E), antibiotics (neomycin, polymyxin B, gentamicin), and other therapeutic components into one unified product. This merging approach maintains high therapeutic effectiveness by providing comprehensive wound care while simplifying the treatment regimen compared to using multiple separate medications

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent achieves universality by designing a multi-functional ointment that simultaneously performs epithelialization promotion, infection prevention, anti-inflammatory action, and wound moisture maintenance. This single formulation replaces multiple specialized treatments, reducing formulation and application complexity while maintaining or improving overall therapeutic effectiveness through the synergistic action of its multiple components

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS11737998B2Composition for treating burn wounds
Publication Date: 2023.08.29 XIE YAN
  • US11737998B2 patent drawing
  • US11737998B2 patent drawing
  • US11737998B2 patent drawing

AI summary

A composition for treating a burn wound, containing a variety of ingredients, including a fatty acid 261-639 mg, an organic substance 3.5-350 mg, a carbohydrate 0.02-60 mg, a vitamin 9-13 μg, a microelement 3.04-5.5 mg, an antibiotic 0.6-70 mg, and an amino acid 105-335 mg. The significant therapeutic effects include effectively promoting repair of a burn wound, anti-infection, inhibiting scar hyperplasia, no toxic side effect, convenient use, fast absorption, economical efficiency, etc. The composition provides patients with an efficient, economical, convenient and practical treatment for burn wounds, which greatly reduces the burden on patients, and effectively compensates for the various deficiencies of the current treatments for the non-healing burn wounds.